Anthropic files for proposed public offering

Anthropic said it filed a Form S-1 registration statement with the SEC for a proposed IPO of its Class A common stock.[1] The company intends to list the shares on the Nasdaq Global Select Market under the ticker ANT.[1] It has not yet determined how many shares it will offer or the proposed price range.[1] The securities may not be sold before the registration statement becomes effective.[1] For prospective investors and advisers, that means the filing is an early step in the process, not a completed offering with final terms.[1]

Anthropic’s co-founders say their aim is to help humanity navigate technological change safely, open new frontiers of discovery and bring about what they call an age of miracles.[3] The prospectus cites curing cancer as one possible benefit of AI, as well as a practical example: shorter lines at motor vehicle departments.[3] It also warns that increasingly capable and autonomous AI systems could take harmful actions independently and at scale without human intervention.[3] The document therefore presents potential benefits alongside a direct concern about what greater autonomy could mean.[3]

Fortune’s account of the filing says Anthropic’s revenue grew 1,300% in the first half of the year.[3] It also reports a net loss of $80.7 billion for the six months through June 2026, including a $72.4 billion accounting charge tied to the increased value of convertible notes the company had issued.[3] The same account says operating loss narrowed to $693 million in the first half of 2026, from $2.1 billion in the same period of 2025, and cash generation was $3.9 billion, versus negative cash flow of $1.5 billion a year earlier.[3] Anthropic also said it had $1.6 billion in operating income in the first half of the year; the supplied figures do not explain how that differs from the reported operating loss.[3]

Anthropic said its five largest customers generated about 25% of its revenue in the first nine months of 2026.[3] That figure offers one measure of customer concentration.[3] Investors and business partners assessing the filing should distinguish the reported concentration figure from a fuller account of customer mix, which is not provided in the evidence here.[3]